Pre-market: Auxly (XLY.TO) TSX earnings 26 Mar 2026: guidance key

We are watching XLY.TO stock in pre-market trade ahead of Auxly Cannabis Group Inc.’s earnings due 26 Mar 2026. The market quote shows C$0.15 and intraday range C$0.13–C$0.15, with volume already above average at 1,748,944 shares. Investors will focus on guidance, margins, and cash flow given the company reports at 08:30 EDT and recent operational improvements.

Pre-market snapshot: XLY.TO stock

Auxly Cannabis Group Inc. (XLY.TO) trades on the TSX and opens pre-market near C$0.15, up 3.57% on the day. Volume is 1,748,944, well above the average of 694,969, implying elevated interest ahead of the earnings release.

The stock’s 52-week range is C$0.07–C$0.19. Short-term momentum indicators show RSI near 60.54, suggesting room to run if earnings beat estimates.

Earnings setup and calendar: XLY.TO stock earnings

Auxly announces results on 26 Mar 2026 at 08:30 EDT. Market focus will be on revenue growth, margin trends, and any updated 2026 guidance. Analysts and traders will watch commentary on branded products like KOLAB PROJECT and Dosecann for demand signals.

Auxly reports trailing EPS of C$0.04 and a low reported PE near 3.50, making the release a potential catalyst for a sharp move in either direction.

Valuation and financials: XLY.TO stock analysis

Auxly shows improving profitability with net profit margin near 31.05% and ROE at 32.74%. Key metrics include price-to-sales around 1.29, price-to-book near 1.09, and enterprise value to EBITDA about 4.16, indicating value relative to peers.

Leverage is moderate with debt-to-equity near 0.38 and current ratio at 1.93, which supports a view that Auxly can fund near-term growth without aggressive refinancing.

Meyka grade and forecast: XLY.TO stock

Meyka AI rates XLY.TO with a score out of 100: 78.00 (Grade B+, Suggestion: BUY). This grade factors in S&P 500 comparison, sector and industry peers, financial growth, key metrics, forecasts, and analyst sentiment. These grades are informational and not investment advice.

Meyka AI’s forecast model projects monthly C$0.13, yearly C$0.23, and three-year C$0.42. Compared to the current price C$0.145, the model implies a near-term downside of -10.34% to the monthly target and an implied one-year upside of 60.80%. Forecasts are model-based projections and not guarantees.

Technical and trading setup: XLY.TO stock technicals

Technical indicators show an ADX of 40.36 indicating a strong trend and a CCI at 110.68, which signals short-term overbought conditions. Bollinger Bands sit at C$0.11–C$0.14, placing the current price at the upper band.

Traders should note on-balance volume is negative and momentum is mixed. A clear earnings beat could lift the stock above the year high of C$0.19.

Risks and catalysts: XLY.TO stock outlook

Catalysts include stronger-than-expected branded product demand, improved gross margins, and positive guidance on distribution. M&A or margin expansion commentary could spur follow-through buying.

Risks include weaker retail demand, inventory build, or conservative guidance. Regulatory shifts in Canada’s cannabis market would also materially affect shares and sector comparisons.

Final Thoughts

Key takeaways for XLY.TO stock: Auxly enters the 26 Mar 2026 earnings with C$0.15 in pre-market trade and above-average volume. Financials show improving profitability, low reported PE near 3.50, and manageable leverage. Meyka AI’s model projects a one-year target of C$0.23, implying 60.80% upside from the current C$0.145 price, while the one-month view implies -10.34% downside. Our view is data-driven: a clear beat on revenue and margins should validate the Meyka grade (B+, Buy), while weak guidance will likely pressure the stock toward the lower end of its range. Use earnings commentary and cash-flow signals to judge near-term direction. For live updates see Auxly on Meyka AI and official filings

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.